The Latest Breaking News from Moderna

Moderna stock has bounced off its 52-week low but still looks incredibly weak.

Investing in IPOs may sound exciting, but it's often better to wait for newly public stocks to mature before buying.

Moderna stock tumbled Thursday after the Covid vaccine maker handily beat third-quarter sales forecasts, but issued light guidance.

Investors fearing a brutal stock market crash are still waiting with dread. But it's already arrived for a group of battered S&P 500 stocks.

Back in May, the World Health Organization declared an end to the global Public Health Emergency for Covid-19. Despite the end of the pandemic, however, the healthcare industry is still feeling its effects. Vaccine makers and pharmacy chains are seeing a steep decline in the number of people getting Covid...

Many people first became familiar with the term “mRNA” when Pfizer’s and Moderna’s COVID vaccines were rolled out. In the simplest terms, mRNA, which stands for messenger ribonucleic acid, is a type of genetic material that gives cells in our bodies instructions to make specific proteins.

The stock market remained positive with the major indexes all gaining around 1%. Retail stock rises on news it will get added to the S&P 500 Index.

Moderna stock and BioNTech stock led a sell-off Monday among Covid vaccine makers after Pfizer slashed its full-year guidance.

Moderna announces plans to move a novel vaccine design into its final stage of development